This association did not reach statistical significance in the pooled dataset, with patients with blood group other than O having a 1.46 times greater risk (95% CI 0.94–2.31).
← all excerpts
Risk stratification integrating genetic data for factor VIII inhibitor development in patients with severe hemophilia A.
1
—
—